Search Results 91-100 of 16631 for primary sclerosing cholangitis
... primary sclerosing cholangitis (PSC). However, ERCP has some associated risks, and not all patients with PSC will benefit from undergoing this procedure ...
Primary sclerosing cholangitis is a disease that affects bile ducts, which carry the digestive liquid bile from the liver to the small intestine. The ...
A Study to Find Consensus in the Definition and Management of Dominant Strictures in Primary Sclerosing Cholangitis · Overview · Participation eligibility.
Study Investigating the Activity of Vidofludimus Calcium as a Treatment for Primary Sclerosing Cholangitis (PSC) · Overview · Participation eligibility.
A Study to Evaluate the Effectiveness and Safety of Obeticholic Acid to Treat Patients with Primary Sclerosing Cholangitis · More about research at Mayo Clinic.
Primary sclerosing cholangitis is a major risk factor for cirrhosis, colon cancer and cholangiocarcinoma. After diagnosis, many patients have a liver transplant ...
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows ...
The purpose of this study is to to evaluate the effectiveness and safety of Saroglitazar Magnesium's optimal dose (1 or 2 mg) and placebo in subjects with ...
In the following model, short-term survival probability of a patient with primary biliary cholangitis is estimated based on repeated observation.
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.